ResMed Inc.
Organization details
- Legal name
- ResMed Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- RMD
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000943819
- EIN
- 98-0152841
- Wikidata ID
- Q7314903
Board of directors
-
Carol Burt · DirectorSince 2023
-
Christopher DelOrefice · DirectorSince 2024
-
Desney Tan · DirectorSince 2023
-
Harjit Gill · DirectorSince 2023
-
John Hernandez · DirectorSince 2023
-
Karen Drexler · DirectorSince 2023
-
Michael J. Farrell · Director · Chairman and CEOSince 2025
-
Nicole Mowad-Nassar · DirectorSince 2025
-
Peter C. Farrell · DirectorSince 2023
-
Richard Sulpizio · DirectorSince 2023
-
Ronald R. Taylor · DirectorSince 2023
-
Witte Jan De · DirectorSince 2023
Chief executives
Director election results
Annual meeting of November 19, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.3%
-
94.2%
-
94.9%
-
96.2%
-
98.1%
-
98.3%
-
98.6%
-
99.1%
-
99.2%
-
99.9%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Arcturus Therapeutics Holdings Inc. Same sectorvia Peter C. Farrell
-
Evolus Inc. Same sectorvia Peter C. Farrell
-
IQVIA Holdings Inc. Same sectorvia Carol Burt
-
Integra LifeSciences Holdings Corporation Same sectorvia Witte Jan De
-
Outset Medical Inc. Same sectorvia Karen Drexler
-
Valion Bio Inc. Same sectorvia Karen Drexler
-
Zimmer Biomet Holdings Inc. Same sectorvia Michael J. Farrell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,492,468
- 29 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2026 | Rider Michael J Officer (Global General Counsel) | Open-market sale | −400 | $255.00 | $102,000 |
| Oct 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Option exercise | +4,991 | $146.34 | $730,383 |
| Oct 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Open-market sale | −4,991 | $226.33 | $1,129,637 |
| Sep 8, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Option exercise | +4,991 | $146.34 | $730,383 |
| Sep 8, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Open-market sale | −4,991 | $222.44 | $1,110,198 |
| Sep 2, 2026 | Peter C. Farrell Director | Open-market sale | −970 | $234.73 | $227,688 |
| Aug 14, 2026 | Bloomer Aaron Officer (Chief Financial Officer) | Grant or award | +9,072 | — | — |
| Aug 14, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Grant or award | +13,547 | — | — |
| Aug 14, 2026 | Leong Justin Officer (Chief Product Officer) | Grant or award | +6,461 | — | — |
| Aug 14, 2026 | Rider Michael J Officer (Global General Counsel) | Grant or award | +3,230 | — | — |
| Aug 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Option exercise | +4,991 | $146.34 | $730,383 |
| Aug 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Open-market sale | −4,991 | $205.69 | $1,026,599 |
| Aug 5, 2026 | Peter C. Farrell Director | Open-market sale | −8,000 | $225.00 | $1,800,000 |
| Jul 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Option exercise | +4,991 | $146.34 | $730,383 |
| Jul 7, 2026 | Michael J. Farrell Director, Officer (Chairman and CEO) | Open-market sale | −4,991 | $218.55 | $1,090,783 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about ResMed Inc.
Who is the CEO of ResMed Inc.?
Michael J. Farrell is ResMed Inc.'s Chairman and CEO.
How many directors are on ResMed Inc.'s board?
ResMed Inc.'s board has 12 directors: Carol Burt, Christopher DelOrefice, Desney Tan, Harjit Gill, John Hernandez, Karen Drexler, Michael J. Farrell, Nicole Mowad-Nassar, Peter C. Farrell, Richard Sulpizio and 2 others.
Are ResMed Inc. insiders buying or selling shares?
Over the last 12 months, ResMed Inc. insiders made no open-market purchases and sold $19.5 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="resmed-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.